跳至主要内容
临床试验/NCT04904315
NCT04904315Unknown不适用

An Exploratory, Multicenter, Observational Study to Examine RNA Biomarkers of Psoriasis Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2).

Mindera Health0 个研究点目标入组 100 人开始时间: 2021年8月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
主要终点
Observation of on therapy transcriptomics to potentially aid in new therapeutic targets

研究概览

简要总结

A 16 week study to examine if baseline or on-therapy transcriptomics can be used to help predict selection of medications and provide new therapeutic targets for drug development in psoriasis subjects.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Observation of on therapy transcriptomics to potentially aid in new therapeutic targets

时间窗: 16 weeks

To examine if baseline or on-therapy transcriptomics can be used to help predict selection of medications and provide new therapeutic targets for drug development in psoriasis subjects by collecting RNA and examining changes in PASI scores at the Week 4, 12, and 16 timepoints.

次要结局

未报告次要终点

研究者

发起方
Mindera Health
申办方类型
Industry
责任方
Sponsor

相似试验